BMAC vs. PRP Therapy: Understanding Their Key Differences
While BMAC and Platelet-Rich Plasma (PRP) therapy are both regenerative treatments, their primary difference lies in their composition and potential applications. PRP is derived from blood and primarily contains concentrated platelets and growth factors, making it most effective for stimulating healing in osteoarthritic joints and soft tissues like ligaments and tendons.
BMAC, on the other hand, includes a broader range of regenerative components, such as mesenchymal stem cells, which differentiate into various tissue types and promote more healing in more complex scenarios. This makes BMAC particularly beneficial for more severe injuries or conditions where stem cells play a pivotal role in tissue repair.
PRP and BMAC are often used together to treat conditions including moderate to severe osteoarthritis, larger tendon tears, hip and shoulder labral tears, meniscus tears, disc degeneration, disc annular tears, and bone injury (e.g., bone marrow edema). In addition, if a patient has 2 or more large structural injuries, the higher volume of regenerative therapy with BMAC and PRP together can be used to treat a greater expanse of injury.